PC | AO | AD | GD | NGS-LSD | Initial signs | Diagnostic suspicions | Biochemical-histopathology studies* | Other genetic studies* |
---|---|---|---|---|---|---|---|---|
P1 | 2Y | - | 12Y | CLN5 | Clumsiness, frequent falls, apraxic gait | CLN | VL; SBIOP + . | PPT1, TTP1 |
P2 | 4Y | - | 7Y | CLN6 | Clumsiness, myoclonic movements | GM2, GCL, MLD, Fabry, Schindler, MANSA, MANBA, MPS, CLN | EA: HEXA, HEXB, GLA, NAGA, MANBA, MAN2B1, MPS, GALC, ARSA, PPT1, TTP1 | MFSD8 |
P3 | 3Y | - | 16Y | CLN3 | Language regression, school inattention, social isolation | CDG, GM1, GM2, GSL, Schindler, GSD II, III, CLN | VL; FC; SPA ; EA: GLB1, HEXB, CTSA, NAGA, GAA, AGL; SBIOP + . | |
P4 | 2Y | - | 23Y | CLN7 | Language delay, clumsiness | CLN | SBIOP +; EA: CLN2. | CLN1 |
P5 | 4Y | - | 16Y | CLN3 | Conduct disorder, attention deficit disorder | CLN | VL +; SBIOP, MBIOP, NBIOP + . | PPT1, TTP1, CLN3, CLN5, CLN8 |
P6 | 3Y | 4Y | 7Y | MLD | Leukodystrophy | Spastic paraparesia | EA: ARSA + | |
P7 | 1Y | - | 9Y | GM1 | Global developmental delay, gait instability | CDG; RCCD; INAD | MBI; NBIOP +; MBS; SPA; EA: HEXA, HEXB | |
P8 | 2Y | 7Y | 4Y | GM2 | Language delay, conduct disorder | Unspecific global developmental delay, Neurodegenerative disease; CLN, GM2 | SBIOP; MBS; EA: HEXA + . | Caryotype; Fragile X; Smith-Magenis |
P9 | 2Y | - | 14Y | GM2 | Clumsiness, frequent falls | Ataxia, Attention deficit disorder | MBI | Caryotype; Fragile X; CGH-60 k array. |
P10 | 3Y | 9Y | 12Y | GM1 | Clumsiness, frequent falls, language delay | RS, MPSIII, GM1 | MBS, U-GAGs; EA: GLB1+ | Caryotype, Fragile-X, MECP2 |
P11 | 5Y | - | 22Y | GM2 | Learning problems, language difficulties | CLN | SBIOP | CLN3, CLN8 |
P12 | 13Y | - | 18Y | NPC2# | Clumsiness, short stature | MTDPS; RCCD; SCA; DRPLA | MBIOP; RCCFS; EA: muscular Coenzima Q10 | mtADN(muscle); MTATP6; tRNALeu(UUR); SCA1,2,3,6,7,12,17; ATN1 |
P13 | 18 M | - | 4Y | ML II,III | Growth delay, macrocephaly | MPS | U-GAGs | SHOX |
P14 | 12 M | 3Y | 3Y | GM2 | Psycomotor regression, language regression | RS, GM2 | EA: HEXA +, HEXB | MECP2 |
P15 | 0 M | 3 M | 1Y | GM1 | Hypotonia, hepatomegaly, cardiomyopathy, bony abnormalities | GSD II | EA: GAA | |
P16 | 9 M | 2Y | 2Y | MPSVI | Bilateral costal deformity, macrocephaly | AA, MPS | U-GAGs, Dermatan sulfate in urine, EA: ARSB | |
P17 | 0 M | - | 2Y | ML II,III | Hypotonia, microcephaly, jaundice | MPS | MBS, U-OLG, U-GAGs | Caryotype; CGH array |
P18 | 2 M | 3Y | 6Y | MPSII | Bilateral inguinal hernia | MPS | U-GAGs; EA: IDS + | |
P19 | 1Y | 4Y | 5Y | MPSI | Clubfoot, arthrogryposis, clawed hands | MPS | U-GAGs; EA: IDUA +, IDS, ARSB | |
P20 | 0 M | 1Y | 1Y | GM1 | Hypotonia, severe psycomotor delay | GM1, GM2, GSL, ML I | MBS; VL; U-GAGs; EA: GBL1 +, HEXA, HEXB, CTSA, NEU1 | |
P21 | 18 M | 3Y | 3Y | GM2 | Unsteady gait, frequent falls | TORCH, Leukodystrophy | EA: | |
P22 | 2Y | - | 6Y | CLN8 | Cognitive regression, epilepsy | Lennox syndrome, CLN | PBIOP + | |
P23 | 3Y | - | 9Y | CLN10 | Psycomotor regression, dystonia, epilepsy | Neuroaxonal dystrophy, sphingolipidosis | MBIO | mtDNA |
P24 | 3Y | 5Y | 23Y | MPSIIIB | Language delay, conduct disorder, learning disabilities, hypoacusia | MPS | Heparan sulfate + | |
P25 | 1Y | - | 6Y | GM2AB | Developmental delay, regression | GM2, GSD II | EA: HEXA, HEXB, GAA (+); HPS GM2 + | GAA |
P26 | 4Y | - | 25Y† | CLN8 | Cognitive regression, epilepsy | CLN | CLN6 |